Analysis of the BACE1 and Clusterin Genes Expression Levels in Alzheimer’s Disease
PDF

Original Investigation

Analysis of the BACE1 and Clusterin Genes Expression Levels in Alzheimer’s Disease

J Acad Res Med 2019;9(1):45-49 DOI: 10.5152/jarem.2019.2671
, , , ,
PDF
Permissions

Abstract

Conclusion:

Our study showed that the blood mRNA levels of the BACE1 and CLU genes were associated with AD.

Results:

The BACE1 and CLU genes were found 14-fold and 13-fold more expressed in the blood of the AD group than on the control group, respectively.

Methods:

The expression levels of CLU and BACE1 in blood samples of subjects were examined using the real-time polymerase chain reaction (RT-PCR). The expression levels of patient and control groups were calculated using the 2-ΔΔCt method. The Statistical Package for Social Sciences (SPSS) version 22 (IBM Corp., Armonk, NY, USA) was used for statistical analysis, and a p of ˂0.05 was accepted as statistically significant.

Objective:

This study aimed to explore the mRNA expressions of the β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) and clusterin (CLU) genes in blood samples of patients with Alzheimer’s disease (AD) and healthy subjects.

Keywords: BACE1, clusterin, alzheimer’s disease, gene expression